Статті в журналах з теми "Genetically engineered drugs"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Genetically engineered drugs".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Jones-Grizzle, Amy J., and J. Lyle Bootman. "Pharmacoeconomics of Genetically Engineered Drugs." PharmacoEconomics 1, no. 1 (January 1992): 45–53. http://dx.doi.org/10.2165/00019053-199201010-00009.
Повний текст джерелаKishore, Kamal, and Pawan Krishan. "Pharmacology of recombinant or genetically engineered drugs." Journal of Young Pharmacists 1, no. 2 (2009): 141. http://dx.doi.org/10.4103/0975-1483.55747.
Повний текст джерелаKhobeysh, M. M., and E. V. Sokolovskiy. "Genetically engineered biologics to treat psoriasis. Experience with ustekinumab in an adolescent with severe psoriasis." Meditsinskiy sovet = Medical Council, no. 1 (March 12, 2023): 123–29. http://dx.doi.org/10.21518/ms2023-003.
Повний текст джерелаМатюнова, Алла, Alla Matyunova, Людмила Брегель, and Lyudmila Bregel. "MODERN JUVENILE IDIOPATHIC ARTHRITIS THERAPY OF WITH THE USE OF BIOLOGICAL MEDICATIONS IN A REGIONAL CHILDREN”S 3 LEVEL HOSPITAL - RESULTS AND PROBLEMS." Acta biomedica scientifica 2, no. 5 (January 18, 2018): 102–6. http://dx.doi.org/10.12737/article_5a3a0e4744a0a8.88140750.
Повний текст джерелаHuang, Ya Qiong, Kenneth L. White, De Shun Shi, Xu Jian Chen, Jia Zhou Li, Shi Yuan Zeng, Shi Hua Zhao, and Gui Wen Ruan. "Development and Prospect of Genetically Engineered Pharmaceutics." Advanced Materials Research 746 (August 2013): 588–92. http://dx.doi.org/10.4028/www.scientific.net/amr.746.588.
Повний текст джерелаZyryanov, S. K., and O. I. Butranova. "Genetically engineered drugs for treatment of bronchial asthma: recent achievements." Russian Pulmonology 28, no. 5 (December 24, 2018): 584–601. http://dx.doi.org/10.18093/0869-0189-2018-28-5-584-601.
Повний текст джерелаLeonova, K. "Selected problems in the use of genetic engineering biological therapy in patients with rheumatoid arthritis." Clinical Medicine and Pharmacology 6, no. 4 (February 2, 2021): 36–39. http://dx.doi.org/10.12737/2409-3750-2021-6-4-36-39.
Повний текст джерелаAvdeev, Sergey N., Alexandr V. Emelyanov, Oksana M. Kurbacheva, Irina M. Marusenko, Pavel I. Novikov, Olga A. Rizakhanova, and Larisa V. Shul’zhenko. "A new delivery device for benralizumab (autoinjector, pen-injector device) in the clinical practice of treating severe eosinophilic asthma: Conclusion of the Expert Council." PULMONOLOGIYA 31, no. 6 (December 16, 2021): 776–81. http://dx.doi.org/10.18093/0869-0189-2021-31-6-776-781.
Повний текст джерелаCho, Kyungjoo, Simon Weonsang Ro, Sang Hyun Seo, Youjin Jeon, Hyuk Moon, Do Young Kim, and Seung Up Kim. "Genetically Engineered Mouse Models for Liver Cancer." Cancers 12, no. 1 (December 19, 2019): 14. http://dx.doi.org/10.3390/cancers12010014.
Повний текст джерелаSamigullina, R. R., V. I. Mazurov, and E. A. Trofimov. "Characteristics of complex therapy of immuno-inflammatory rheumatic diseases in COVID-19 pandemic conditions." Russian Medical Inquiry 5, no. 5 (2021): 260–67. http://dx.doi.org/10.32364/2587-6821-2021-5-5-260-267.
Повний текст джерелаZaytseva, Svetlana V., Anna U. Tomilova, Olga V. Zaytseva, Olga B. Voronina, Olga A. Murtazaeva, Valeriy A. Mukhortykh, and Irina N. Tsymbal. "Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma." Pediatric pharmacology 18, no. 6 (November 16, 2021): 460–68. http://dx.doi.org/10.15690/pf.v18i6.2325.
Повний текст джерелаDorogoykina, K. D. Dorogoykina, D. S. Sedov Sedov, K. A. Gamayunova Gamayunova, and A. P. Rebrov Rebrov. "Kidney condition in patients with spondyloarthritis receiving genetically engineered biologic drugs." Nephrology 2_2020 (June 29, 2020): 21–25. http://dx.doi.org/10.18565/nephrology.2020.2.21-25.
Повний текст джерелаZhuravleva, L. "Problems of diagnosis and treatment of systemic lupus erythematosus in a young girl." Clinical Medicine and Pharmacology 8, no. 4 (February 1, 2023): 30–32. http://dx.doi.org/10.12737/2409-3750-2023-8-4-30-32.
Повний текст джерелаNovoderezhkina, Evgeniya A., and Sergey K. Zyryanov. "Estimating the indirect costs associated with psoriasis." Kazan medical journal 103, no. 5 (October 3, 2022): 824–31. http://dx.doi.org/10.17816/kmj2022-824.
Повний текст джерелаSvechnikova, E. V., and S. E. Zhufina. "A modern view on the treatment of psoriatic disease. Experience in using genetically engineered biological therapy in patients with extensive moderate to severe psoriasis." Meditsinskiy sovet = Medical Council, no. 6 (April 27, 2022): 216–25. http://dx.doi.org/10.21518/2079-701x-2022-16-6-216-225.
Повний текст джерелаDidenko, V. V., G. A. Kalashnik, Ju Ju Karpenko, and E. N. Harlamova. "Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis." Russian Archives of Internal Medicine 11, no. 3 (May 31, 2021): 225–28. http://dx.doi.org/10.20514/2226-6704-2021-11-3-225-228.
Повний текст джерелаKruglova, L. S., A. A. Hotko, and M. Yu Pomazanova. "Issues of switching therapy when effect of biological genetically engineered drugs escapes." Medical alphabet, no. 24 (December 20, 2020): 48–52. http://dx.doi.org/10.33667/2078-5631-2020-24-48-52.
Повний текст джерелаSvechnikova, E. V., Z. B. Marshani, K. A. Fomin, and E. Yu Evdokimov. "Genetically engineered biological drugs in psoriasis treatment in the COVID-19 pandemic." Klinicheskaya dermatologiya i venerologiya 20, no. 5 (2021): 95. http://dx.doi.org/10.17116/klinderma20212005195.
Повний текст джерелаPrimrose, S. B. "The application of genetically engineered micro-organisms in the production of drugs." Journal of Applied Bacteriology 61, no. 2 (August 1986): 99–116. http://dx.doi.org/10.1111/j.1365-2672.1986.tb04263.x.
Повний текст джерелаMeshcherina, N. S., L. A. Knyazeva, I. I. Goryainov, and L. I. Knyazeva. "Vasoprotective Effects of Genetically Engineered Biologic Drugs in Patients with Rheumatoid Arthritis." Sovremennye tehnologii v medicine 7, no. 3 (September 2015): 130–37. http://dx.doi.org/10.17691/stm2015.7.3.18.
Повний текст джерелаKagramanova, Anna V., Oleg V. Knyazev, Oleg V. Knyazev, Oleg V. Knyazev, Dmitrii S. Kulakov, Dmitrii S. Kulakov, Dmitrii S. Kulakov, et al. "Interdisciplinary approach is a key of efficient treatment in patients with immunoinflammatory diseases. Case report." Consilium Medicum 23, no. 5 (2021): 440–43. http://dx.doi.org/10.26442/20751753.2021.5.200821.
Повний текст джерелаKruglova, L. S., E. A. Shatokhina, A. S. Polonskaya, and A. Yu Syryseva. "Choice of frst drug of genetically engineered therapy: Benefts of guselcumab." Medical alphabet, no. 8 (May 18, 2022): 48–55. http://dx.doi.org/10.33667/2078-5631-2022-8-48-55.
Повний текст джерелаTarasova, D. D., L. N. Shilova, M. V. Korolyova, E. G. Korenskaya, and A. V. Feoktistova. "Ulcerative colitis in combination with ankylosing spondylitis: clinical case." Experimental and Clinical Gastroenterology 183, no. 11 (November 14, 2020): 147–50. http://dx.doi.org/10.31146/1682-8658-ecg-183-11-147-150.
Повний текст джерелаVarticovski, L., M. G. Hollingshead, M. R. Anver, A. I. Robles, J. E. Green, K. W. Hunter, G. Merlino, et al. "Preclinical testing using tumors from genetically engineered mouse mammary models." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 10067. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10067.
Повний текст джерелаShilova, L. N., and S. S. Spitsina. "Possibilities of personalized approach to genetically engineered biological therapy of rheumatoid arthritis." Medical alphabet, no. 16 (August 19, 2021): 35–40. http://dx.doi.org/10.33667/2078-5631-2021-16-35-40.
Повний текст джерелаMohd Janib, Siti Najila, Radu O. Minea, Steve D. Swenson, ShuangLong Liu, Martha K. Pastuszka, Frank S. Markland, Peter S. Conti, ZiBo Li, and J. Andrew Mackay. "The Design of Elastin-Like Polypeptides (ELPs) as a Nanoparticulate-Based Therapeutic and Diagnostic Imaging Agent." Advanced Materials Research 1024 (August 2014): 287–91. http://dx.doi.org/10.4028/www.scientific.net/amr.1024.287.
Повний текст джерелаKalmykov, R. S., E. M. Safonenkov, and L. P. Zharkova. "THE USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR THERAPY WITH SARS-COV-2." Вестник Смоленской государственной медицинской академии 21, no. 2 (2022): 49–53. http://dx.doi.org/10.37903/vsgma.2022.2.7.
Повний текст джерелаKito, Hiroyuki, Fumiaki Suzuki, Shunji Nagahara, Yasuhide Nakayama, Yoko Tsutsui, Nobumasa Tsutsui, Nobuyuki Nakajima, and Takehisa Matsuda. "A Total Delivery System of Genetically Engineered Drugs or Cells for Diseased Vessels." ASAIO Journal 40, no. 3 (July 1994): M260—M266. http://dx.doi.org/10.1097/00002480-199407000-00005.
Повний текст джерелаBalabanova, Rimma Mikhailovna, V. N. Amirdzhanova, and E. L. Nasonov. "USE OF GENETICALLY ENGINEERED BIOLOGICAL DRUGS FOR RHEUMATOID ARTHRITIS IN THE RUSSIAN FEDERATION." Rheumatology Science and Practice, no. 6 (December 15, 2012): 10. http://dx.doi.org/10.14412/1995-4484-2012-1286.
Повний текст джерелаHwang, Insung. "Change in Regulation is Necessary for Genetically Engineered Mosquitoes." Michigan Journal of Environmental & Administrative Law, no. 6.1 (2016): 285. http://dx.doi.org/10.36640/mjeal.6.1.change.
Повний текст джерелаMazhar, Sayyeda Farwa, Muhammad Afzal, Ahmad Almatroudi, Samman Munir, Usman Ali Ashfaq, Maria Rasool, Hammad Raza, Hafiz Muhammad Waqas Munir, Muhammad Shahid Riaz Rajoka, and Mohsin Khurshid. "The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics." Journal of Food Quality 2020 (April 7, 2020): 1–11. http://dx.doi.org/10.1155/2020/9676452.
Повний текст джерелаProtzer, U., and H. Abken. "Can Engineered “Designer” T Cells Outsmart Chronic Hepatitis B?" Hepatitis Research and Treatment 2010 (September 21, 2010): 1–9. http://dx.doi.org/10.1155/2010/901216.
Повний текст джерелаDoehmer, J., A. Seidel, F. Oesch, and H. R. Glatt. "Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide." Environmental Health Perspectives 88 (August 1990): 63–65. http://dx.doi.org/10.1289/ehp.908863.
Повний текст джерелаDmitrieva, A. A., and E. V. Dmitriev. "Risks of uveitis recurrence in juvenile idiopathic arthritis." Modern technologies in ophtalmology, no. 6 (November 9, 2022): 71–75. http://dx.doi.org/10.25276/2312-4911-2022-6-71-75.
Повний текст джерелаChesi, Marta, Geoffrey M. Matthews, Victoria M. Garbitt, Stephen E. Palmer, Jake Shortt, Marcus Lefebure, A. Keith Stewart, Ricky W. Johnstone, and P. Leif Bergsagel. "Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy." Blood 120, no. 2 (July 12, 2012): 376–85. http://dx.doi.org/10.1182/blood-2012-02-412783.
Повний текст джерелаNekhaeva, Tatyana, A. Chernov, Yana Toropova, Mikhail Galagudza, and Irina Baldueva. "VARIETY OF TUMOR MODELS FOR TESTING ANTITUM TREATMENT ACTIVITY OF SUBSTANCES IN MICE." Problems in oncology 66, no. 4 (April 1, 2020): 353–63. http://dx.doi.org/10.37469/0507-3758-2020-66-4-353-363.
Повний текст джерелаBurashnikova, I. S. Burashnikova. "The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19." Pharmateca 8_2021 (August 16, 2021): 11–14. http://dx.doi.org/10.18565/pharmateca.2021.8.11-14.
Повний текст джерелаSatybaldyev, Azamat Makhmudovich. "Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)." Modern Rheumatology Journal, no. 1 (March 15, 2013): 30. http://dx.doi.org/10.14412/1996-7012-2013-2364.
Повний текст джерелаMeghani, Zahra. "Genetically Engineered Animals, Drugs, and Neoliberalism: The Need for a New Biotechnology Regulatory Policy Framework." Journal of Agricultural and Environmental Ethics 30, no. 6 (November 21, 2017): 715–43. http://dx.doi.org/10.1007/s10806-017-9696-1.
Повний текст джерелаStolyarov, I. D., G. N. Bisaga, M. V. Votintseva, A. G. Ilves, I. G. Nikiforova, N. V. Nikolaeva, M. S. Rudas, et al. "Some modern methods of diagnosis and pathogenetic therapy of multiple sclerosis." Neurology Bulletin XXXIV, no. 1-2 (April 15, 2002): 65–72. http://dx.doi.org/10.17816/nb87566.
Повний текст джерелаAlekseeva, Ekaterina I., Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy, and Natalya E. Tkachenko. "Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review." Current Pediatrics 18, no. 2 (June 23, 2019): 101–8. http://dx.doi.org/10.15690/vsp.v18i2.2012.
Повний текст джерелаRosochkina, E. A., G. V. Lukina, E. N. Koltsova, K. A. Lytkina, E. I. Shmidt, A. I. Zagrebneva, and E. V. Zhilyaev. "Comparative efficacy of genetically engineered biological drugs in real clinical practice according to the Moscow Unified Arthritis Registry (MUAR) data." Russian Medical Inquiry 5, no. 2 (2021): 58–63. http://dx.doi.org/10.32364/2587-6821-2021-5-2-58-63.
Повний текст джерелаSevostyanov, V. K., P. S. Lototskaya, N. V. Babich, D. D. Rassoha, A. S. Novikov, S. L. Balashov, and E. S. Zholobova. "ANALYSIS OF THE SURVIVAL OF GENETICALLY ENGINEERED BIOLOGICAL THERAPY IN JUVENILE IDIOPATHIC ARTHRITIS." Pediatria. Journal named after G.N. Speransky 101, no. 4 (August 19, 2022): 55–63. http://dx.doi.org/10.24110/0031-403x-2022-101-4-55-63.
Повний текст джерелаGalstyan, L. A., E. S. Zholobova, S. N. Chebysheva, A. V. Meleshkina, V. A. Seraya, and O. Yu Loskutova. "Uveitis associated with juvenile idiopathic arthritis." Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 64, no. 2 (May 15, 2019): 30–37. http://dx.doi.org/10.21508/1027-4065-2019-64-2-30-37.
Повний текст джерелаNascimento-Gonçalves, Elisabete, Bruno A. L. Mendes, Rita Silva-Reis, Ana I. Faustino-Rocha, Adelina Gama, and Paula A. Oliveira. "Animal Models of Colorectal Cancer: From Spontaneous to Genetically Engineered Models and Their Applications." Veterinary Sciences 8, no. 4 (April 5, 2021): 59. http://dx.doi.org/10.3390/vetsci8040059.
Повний текст джерелаSiegfried, Michael. "The Inner City in the 21st Century." Journal of Interdisciplinary Studies 8, no. 1 (1996): 19–30. http://dx.doi.org/10.5840/jis199681/22.
Повний текст джерелаBurashnikova, I. S. Burashnikova. "The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19." Pharmateca 8_2021 (August 16, 2021): 15–19. http://dx.doi.org/10.18565/pharmateca.2021.8.15-19.
Повний текст джерелаSizova, Ol'ga Aleksandrovna, Nataliya Vladimirovna Efremova, and Zoya Sergeevna Rumyantseva. "LUNG DAMAGE AS A COMPLICATION OF SYSTEMIC JUVENILE ARTHRITIS." Ulyanovsk Medico-biological Journal, no. 4 (December 26, 2022): 38–48. http://dx.doi.org/10.34014/2227-1848-2022-4-38-48.
Повний текст джерелаMeshcheryakova, A., and A. Vorobyova. "CHRONIC DEMYELINIZING POLYNEUROPATHY: ETIOPATHOGENETIC, CLINICAL ASPECTS, MODERN DIRECTIONS OF MEDICAL THERAPY." National Association of Scientists 1, no. 67 (June 15, 2021): 23–25. http://dx.doi.org/10.31618/nas.2413-5291.2021.1.67.423.
Повний текст джерелаSiddeswari T, Panneerselvam P, Vijayamma G, Nithya Kalyani K, Jeslin D, and Suryasree Y. "Design and validation of the Gingkolide estimation using RP-HPLC analytical tool." International Research Journal of Pharmaceutical and Applied Sciences 11, no. 1 (February 26, 2021): 1–5. http://dx.doi.org/10.26452/irjpas.v11i1.1394.
Повний текст джерела